REZNARE Trademark

Trademark Overview

On Thursday, August 23, 2018, a trademark application was filed for REZNARE with the United States Patent and Trademark Office. The USPTO has given the REZNARE trademark a serial number of 88089465. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 14, 2022. This trademark is owned by Pfizer Inc.. The REZNARE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
reznare

General Information

Serial Number88089465
Word MarkREZNARE
Filing DateThursday, August 23, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 31, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, March 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 9, 2021EXTENSION 5 GRANTED
Thursday, July 1, 2021EXTENSION 5 FILED
Friday, July 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 1, 2021TEAS EXTENSION RECEIVED
Friday, January 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 6, 2021EXTENSION 4 GRANTED
Wednesday, January 6, 2021EXTENSION 4 FILED
Wednesday, January 6, 2021TEAS EXTENSION RECEIVED
Saturday, June 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 25, 2020EXTENSION 3 GRANTED
Thursday, June 25, 2020EXTENSION 3 FILED
Thursday, June 25, 2020TEAS EXTENSION RECEIVED
Thursday, February 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 16, 2020EXTENSION 2 GRANTED
Thursday, January 16, 2020EXTENSION 2 FILED
Thursday, January 16, 2020TEAS EXTENSION RECEIVED
Wednesday, January 15, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 15, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2019EXTENSION 1 GRANTED
Thursday, July 25, 2019EXTENSION 1 FILED
Thursday, July 25, 2019TEAS EXTENSION RECEIVED
Tuesday, February 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 11, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 11, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, October 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 23, 2018ASSIGNED TO EXAMINER
Friday, August 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 27, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

reznare preparations disorders pharmaceutical dysfunction treatment liver erectile blood viral urological